Trials / Completed
CompletedNCT00444106
Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function
An Open-label, Randomized, Single-center, Parallel Group Study of the Effects of Artemether-lumefantrine (Coartem®) Atovaquone-proguanil (Malarone®) and Artesunate-mefloquine on Auditory Function Following the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Patients 12 Years of Age or Older
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 265 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- —
Summary
To evaluate the potential effects of artemether- lumefantrine on the auditory function
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Artesunate-mefloquine | |
| DRUG | Atovaquone-proguanil | |
| DRUG | Artemether-lumefantrine |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-11-01
- Completion
- 2008-11-01
- First posted
- 2007-03-07
- Last updated
- 2011-04-05
- Results posted
- 2011-03-16
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT00444106. Inclusion in this directory is not an endorsement.